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Rationale {#sec1}
=========

The clinical characteristics and pathogenesis of acute exacerbations of chronic rhinosinusitis (AECRS) are poorly understood. Our objective was to identify respiratory viruses during AECRS and measure effects of exacerbations on quality of life (QOL).

Methods {#sec2}
=======

Patients with CRS with or without nasal polyps from a tertiary care allergy-immunology clinic were evaluated for worsening sinonasal symptoms. Visit 1 occurred within 10 days of symptom onset. Visit 2 occurred 6-12 weeks later when symptoms returned to baseline. We detected viruses in nasal lavage via RT-PCR and QOL by SNOT-22 (SinoNasal Outcome Test), WURSS-21 (Wisconsin Upper Respiratory Symptom Survey) and ACQ-6 (Asthma Control Questionnaire).

Results {#sec3}
=======

Thirty-eight patients were enrolled. Thirty-two of 38 (84.2%) patients had asthma, 31 (81.6%) received antibiotics, and 28 (73.7%) received prednisone. Viruses were identified in 13/38 (34.2%) at visit 1 (13.2% Rhinovirus A/B/C, remainder Influenza A/B, Adenovirus, Human Coronavirus HKU1/NL63/OC43, Enterovirus or Metapneumovirus) and in 5/26 (19.2%) at visit 2 (7.7% Rhinovirus A/B, remainder Influenza A/B or Human Coronavirus NL63/HKU1). QOL scores were significantly higher at visit 1 compared to visit 2 (SNOT-22 53.8 ± 18.2 vs 23.7 ± 17.1, p\<0.0001, ACQ-6 8.5 ± 6.8 vs 3.1 ± 3.5, p=0.0001, WURSS-21 37.9 ± 15.3 vs 1.5 ± 5.1, p\<0.0001). There was a trend towards higher symptoms scores in patients with viruses at visit 1 compared to those without. Bacterial pathogen analysis is pending.

Conclusions {#sec4}
===========

Our data suggest a role for viral infection in AECRS and possibly in baseline CRS. QOL data demonstrates that significant symptomatic worsening occurred during exacerbations of CRS.
